Volume 42, number 1: Acute Hearing Loss Due to Scrub Typhus: A Forgotten Complication of a Reemerging Disease
2nd Dec 2005, 23:36 GMT
We describe 6 patients with scrub typhus who presented with acute hearing loss, a forgotten complication of this reemerging disease. They were admitted with fever of 10–14 days' duration and had clinical evidence of deafness and pneumonitis. Five patients had eschars, which prompted the diagnosis of typhus fever and led to early institution of treatment. Deafness has been described as a clue to the diagnosis of scrub typhus; awareness of this symptom facilitated early diagnosis in 4 of 5 patients who recovered. Acute hearing loss or hearing impairment in a febrile patient should arouse strong suspicion of scrub typhus.
Volume 42, number 1: Acute Hearing Loss Due to Scrub Typhus: A Forgotten Complication of a Reemerging Disease related news:
- Volume 42, number 1: Bone Disease and HIV Infection — Clin Infect Dis Latest Issue
- Risedronate prevents bone loss and periodontal disease — News-Medical News Feed
- Regulation of Blood Pressure in the Land Crab Cardisoma guanhumi — Physiol Biochem Zool Latest Articles
- Cochlear's Roberts: "We Have a Unique Opportunity" — BusinessWeek Online -- Technology & Science
- Lightning strike starts scrub blaze — NATIONAL
- Volume 78, number 1: Mutations in a Novel Isoform of TRIOBP That Encodes a Filamentous-Actin Binding Protein Are Responsible for DFNB28 Recessive Nonsyndromic Hearing Loss — Am J Hum Genet Latest Issue
- Liver Transplants May Not Be Indicated For Cystic Fibrosis Patients With Bleeding Complication — Medical News Today RSS/XML Feed
- Organic foods seem to help prevent the dramatic rise in acute lymphoblastic leukemia — The Cancer Blog
- Final Data from Phase II Trial with Gentium's Defibrotide Presented at ASH Annual Meeting — StratWire - Business of Healthcare NewsFeed
- Foxy Brown's Trial Postponed Because of Hearing Loss — TheCelebrityCafe.com Magazine
Latest news from Clin Infect Dis Latest Issue:
- Volume 43, number S4: Buprenorphine and HIV Primary Care: New Opportunities for Integrated Treatment
- Volume 43, number S4: Opioid Dependence: Rationale for and Efficacy of Existing and New Treatments
- Volume 43, number S4: The Potential Role of Buprenorphine in the Treatment of Opioid Dependence in HIV-Infected Individuals and in HIV Infection Prevention
- Volume 43, number S4: A Trial of Integrated Buprenorphine/Naloxone and HIV Clinical Care
- Volume 43, number S4: Initial Strategies for Integrating Buprenorphine into HIV Care Settings in the United States
- Volume 43, number S4: Buprenorphine Use: The International Experience
- Volume 43, number S4: Pharmacokinetic Interactions between Buprenorphine and Antiretroviral Medications
- Volume 43, number S4: Interactions between Buprenorphine and Antiretrovirals. I. The Nonnucleoside Reverse-Transcriptase Inhibitors Efavirenz and Delavirdine
- Volume 43, number S4: Interactions between Buprenorphine and Antiretrovirals. II. The Protease Inhibitors Nelfinavir, Lopinavir/Ritonavir, and Ritonavir
- Volume 43, number S4: Overcoming Policy and Financing Barriers to Integrated Buprenorphine and HIV Primary Care